BofA Securities analyst Craig Bijou downgraded RxSight Inc. (NASDAQ: RXST) from Buy to Underperform with a price target of $22.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE